Emicizumab in Acquired Hemophilia A
Condition(s):Hemophilia A, AcquiredLast Updated:January 9, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Hemophilia A, AcquiredLast Updated:January 9, 2023Completed
Condition(s):Acquired Hemophilia ALast Updated:February 26, 2024Recruiting
Condition(s):Severe Hemophilia ALast Updated:January 19, 2021Completed
Condition(s):Hemophilia ALast Updated:May 24, 2021Completed
Condition(s):Hemophilia ALast Updated:December 28, 2007Completed
Condition(s):Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor; Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor; Hemophilia ALast Updated:March 12, 2024Active, not recruiting
Condition(s):Severe Hemophilia ALast Updated:February 13, 2024Active, not recruiting
Condition(s):Hemophilia ALast Updated:June 6, 2023Active, not recruiting
Condition(s):Hemophilia ALast Updated:April 29, 2021Completed
Condition(s):Hemophilia ALast Updated:March 8, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.